Health Care: Drugs

Inovio Pharmaceuticals Inc (INO: NASDAQ)

$8.285 n/a | n/a%
03/27/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 8.29
52 Week High 14.20
52 Week Low 6.33
Avg. Daily Vol. (Mil) 0.79
Beta (3 year) 3.81
Share Related Items
Mkt Cap (Mil) 503.24
Shares Out (Mil) 60.74
Float (Mil) 56.98
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.90
Current Ratio 7.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 48.13
Price/Book 4.52
Price/Cash Flow -14.60
Per Share Data
Earnings -0.61
Sales 0.17
Book Value 1.83
Cash Flow -0.57
Business Summary
Inovio Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases.
General Information
660 West Germantown Pike
Suite 110
Plymouth Meeting, PA 19462
www.inovio.com
Industry : Drugs
Sector: Health Care
Employees: 106
CEO: Dr. J. Joseph Kim,PhD
Short Interest
Current Month (Mil) 11.43
Previous Month (Mil) 11.80
Short Interest Ratio (Days) 19.50
Management Effectiveness
Return on Equity n.a.
Return on Assets -27.40
Return on Investments -32.50
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with INO

Latest INO Headlines from TheStreet

More Financial News for INO

Press Releases for INO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter